Technical Analysis
Comprehensive insights into market trends, chart patterns, and key indicators. Equip yourself with the tools and strategies to make data-driven trading decisions.
Avita Medical (RCEL) receives a Buy rating and $25 price target from Boral Capital, citing Recell’s potential in treating various skin conditions like burns and wounds. Boral anticipates substantial growth as Recell expands into trauma, surgical, and chronic wound care markets.
Avita Medical: Poised for Growth, Boral Capital Initiates Coverage with Buy Rating Read More »
Vertex Pharmaceuticals stock fell after mixed Phase 2 trial results for its lumbosacral radiculopathy drug, suzetrigine. While the drug reduced pain, the placebo group showed similar improvement, raising questions about its efficacy.
Vertex Pharmaceuticals Stock Falls After Mixed Phase 2 Trial Results Read More »
Ford beat Q4 earnings and full-year profit forecasts, but 2025 guidance is muted due to potential tariff impacts and market factors. The automaker projects a “roughly breakeven” Q1 2025 and lower full-year EBIT, sparking investor concern and a stock price drop.
Ford Posts Q4 Earnings Beat But Issues Muted 2025 Guidance Amidst Tariff Concerns Read More »
DOGE’s access to Treasury systems sparks fears of financial instability and data breaches, drawing criticism from experts and former Treasury secretaries. Aggressive cost-cutting measures, including access to sensitive payment data, raise concerns about national security and a potential U.S. default.
DOGE’s Treasury Access Sparks Financial and Security Concerns Read More »
Barclays exceeded 2024 profit expectations with a 24% surge, driven by strong investment banking and UK lending. The bank raised its 2025 RoTE target to ~11%, signaling confidence despite a complex UK economic landscape.
Barclays Exceeds Profit Expectations, Raises 2025 Targets Read More »
Mobileye (MBLY) stock dropped 28% after a disappointing CES presentation. Technical analysis reveals key support at $15, $12, and $10.50, with resistance at $24.
Mobileye Stock: Key Support and Resistance Levels After CES Presentation Disappoints Read More »
S&P 500’s post-Trump re-election gains almost erased as Inauguration Day nears, potentially marking the worst performance since 2009. Declining tech stocks and impending economic data releases contribute to market uncertainty.
S&P 500’s Post-Election Gains Nearly Vanish as Inauguration Day Approaches Read More »
Estée Lauder stock plunged 18% after Q4 earnings missed expectations, despite beating EPS estimates. Weak revenue and lowered guidance signal market concerns, creating potential buying opportunities for investors.
Estée Lauder Stock Plunges 18% After Disappointing Q4 Results Read More »
MicroStrategy’s leveraged Bitcoin bet loses its luster as options traders grow wary. The stock’s declining correlation with Bitcoin and high implied BTC price suggest waning investor confidence.
MicroStrategy’s Bitcoin Bet Loses Luster as Options Traders Turn Cautious Read More »
CFPB sues Capital One for allegedly evading $2 billion in interest payments to deposit account holders. The lawsuit claims Capital One manipulated accounting practices to reduce interest owed, impacting numerous customers.
Capital One Faces CFPB Lawsuit Over Alleged Interest Payment Evasion Read More »
